# Sinopharm

> Pharmaceutical distribution and research

Business model and tags: B2B, Publicly traded, Manufacturing, Logistics, Retail, Multi-product, Healthcare provider, Pharma & life sciences, Medical devices, Parent company, Public body, Multi-site, International operations, Has physical stores, Has production sites, Has warehouses, Has a vehicle fleet, Has in-house R&D, Distributor or wholesaler, Deskless workforce, Handles regulated data

## About Sinopharm

A leading pharmaceutical and healthcare group in China, specializing in distribution, research, and manufacturing of medical and biotech products

## Key facts

- **Industry**: Pharmaceutical Manufacturing
- **Company size**: 251–1,000 employees
- **Revenue**: $75.5M – $597M (Tamtam estimate)
- **Website**: [sinopharm.com](https://www.sinopharm.com/)
- **LinkedIn**: [linkedin.com/company/sinopharm](https://www.linkedin.com/company/sinopharm)

## Sinopharm account plan

Sinopharm Group runs China's largest national drug and medical device distribution network, with FY2025 revenue of RMB575,167.88 million.

[Read the Sinopharm account plan](https://www.tamtam.ai/c/sinopharm/account-plan)

## Sinopharm in the news

- [ETFs Investing in Sinopharm Group Co., Ltd. Unsponsored ADR Class H Stocks](https://www.tradingview.com/symbols/FWB-X2S1/etfs/) · tradingview.com · Oct 12, 2026
  Exchange-Traded Funds provide an accessible, lower-risk way to invest in Sinopharm Group Co., Ltd. Unsponsored ADR Class H stocks, with data organized by market value.
- [Sinopharm Group Co. Ltd. Advanced Charts | 1099](https://www.barrons.com/market-data/stocks/1099/interactive-chart?countrycode=hk&amp%253Bmod=quotes%252Cquotes%252Cquotes&mod=quotes) · barrons.com · Oct 11, 2026
  This document describes the sources and update frequencies for various financial market data, including stocks, bonds, and cryptocurrencies, noting it's for informational purposes and not trading.
- [Harbour BioMed and Sinopharm Form Strategic Alliance to Accelerate Innovative Biologics](https://www.biopharmaapac.com/news/28/8253/harbour-biomed-and-sinopharm-form-strategic-alliance-to-accelerate-innovative-biologics.html) · biopharmaapac.com · Oct 5, 2026
  Harbour BioMed and Sinopharm created an innovation consortium to accelerate the research, development, and commercialization of new biologic drugs.

[See all 6 articles](https://www.tamtam.ai/c/sinopharm/news)

## Sinopharm at a glance

Sinopharm is a B2B company in the Pharmaceutical Manufacturing industry.

Sinopharm has 251–1,000 employees.

Sinopharm's revenue is $75.5M – $597M (Tamtam estimate).

## Frequently asked questions about Sinopharm

### What is Sinopharm's revenue?

Tamtam estimates Sinopharm's annual revenue at $75.5M – $597M.

### How many employees does Sinopharm have?

Sinopharm has 251–1,000 employees.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/sinopharm
